- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00412269
Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin
Study Overview
Status
Conditions
Detailed Description
The effect of menopause on body composition and cardiovascular risk in healthy caucasian women has been the subject of much study. In contrast, there are few data available on menopause in African-American women. Since menopause is associated with potentially preventable health risks in women, this proposal is aimed at characterizing the perimenopausal period in terms of body fat, energy balance, and insulin action in both caucasian and African-American women.
The study will address 4 general hypotheses:
- Menopause increases both total and visceral abdominal fat
- Changes in body composition and body weight at menopause are mediated, at least in part by changes in 24-hour energy expenditure and/or food intake
- Menopause results in decreased insulin sensitivity that may predispose certain women to develop diabetes later in life
- African-American women may respond to the shifts in reproductive hormones at menopause differently than caucasian women.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 47-52 yr, at time of enrollment
- Body Mass Index 25-40
- Normal oral glucose tolerance test by National Diabetes Data Group criteria
- Premenopausal, defined by FSH levels <30mIU/ml and at least 5 menstrual periods in the last 6 months
- Able to confirm ethnic heritage of past 2 generations in family
Exclusion Criteria:
- hypertension or hypercholesterolemia requiring medication
- regular use of medications that influence glucose tolerance
- use of oral contraceptives within the past 6 months
- history of myocardial infarction or significant coronary vascular disease or stroke
- history of endocrine, kidney, or liver disease or malignancy
- any psychopathology, including eating disorders, substance abuse, and major depression
- unable to complete longitudinal study commitment, including anticipating moving out of the area within the next 5 years.
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Steven R Smith, M. D., Pennington Biomedical Research Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PBRC 97022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasRecruitingMenopause Related ConditionsUnited States
-
Wake Forest University Health SciencesWithdrawnMenopause Related Conditions
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause Related ConditionsRussian Federation